FDA Determines Regulatory Review Period for CYDECTIN Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the patent extension of CYDECTIN, a veterinary drug product, in accordance with federal regulations.